(18)Where ESMA has identified that an OTC derivative product is standardised and suitable for clearing but no CCP is willing to clear that product, ESMA should investigate the reason for this.
Official text · the act as publishedFrom the act as published (consolidated texts do not carry recitals or the preamble).Open full page ↗